{"id":"W3032800512","doi":"10.1200/jco.2020.38.15_suppl.1000","title":"KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Merck","keywords":"Medicine; Gemcitabine; Carboplatin; Internal medicine; Taxane; Pembrolizumab; Oncology; Chemotherapy; Breast cancer; Cancer; Cisplatin; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002383865,0.002309605,0.002486013,0.0005958448,0.0004522738,0.001373079,0.001403442,0.00216683,0.01298043],"category_scores_gemma":[0.001706224,0.0009695612,0.001290835,0.0005409257,0.001185299,0.001225174,0.0005223241,0.002919927,0.002127922],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001153733,"about_ca_system_score_gemma":0.00191137,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009642113,"about_ca_topic_score_gemma":0.002843918,"domain_scores_codex":[0.9992257,0.0003639606,0.00005932926,0.0001692645,0.00006221455,0.0001195171],"domain_scores_gemma":[0.9993049,0.0001357803,0.0002106653,0.00005893199,0.00004410651,0.0002456926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9709743,0.01190172,0.0002480384,0.0007050254,0.0005091185,0.00001814762,0.00002851774,0.0002043679,0.004803839,0.000142405,0.000944718,0.009519918],"study_design_scores_gemma":[0.9475398,0.05065782,0.0005397999,0.00002502841,0.0001764596,0.00001531927,0.000007989892,0.0001884275,0.0003097337,0.00008152535,0.0004504242,0.000007656066],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.945419,0.005319581,0.002255536,0.001050004,0.001300629,0.03260446,0.005206394,0.0005573592,0.006287105],"genre_scores_gemma":[0.9572921,0.002920026,0.004121999,0.002290961,0.0005612362,0.02260521,0.002781644,0.00005649008,0.007370264],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01298043,"threshold_uncertainty_score":0.04342389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1757267021781145,"score_gpt":0.4856334559244245,"score_spread":0.30990675374631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}